| 高雄醫學大學 |
2013 |
Targeting the XIAP/caspase-7 complex selectively kills caspase-3-deficient malignancies
|
Lin, YF;Lai, TC;Chang, CK;Chen, CL;黃明賢;Yang, CJ;Liu, HG;Dong, JJ;Chou, YA;Teng, KH;Chen, SH;Tian, WT;Jan, YH;Hsiao, M;PH , Liang; Lin, YF;Lai, TC;Chang, CK;Chen, CL;Huang, MS;Yang, CJ;Liu, HG;Dong, JJ;Chou, YA;Teng, KH;Chen, SH;Tian, WT;Jan, YH;Hsiao, M;PH , Liang |
| 國立臺灣大學 |
2008 |
Targeting Therapy for Breast Carcinoma by ATP Synthase Inhibitor Aurovertin B
|
Huang, Tsui-Chin; Chang, Hsin-Yi; Hsu, Chun-Hua; Kuo, Wen-Hung; Chang, King-Jen; Juan, Hsueh-Fen |
| 臺大學術典藏 |
2018-09-10T06:56:50Z |
Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B
|
Chang, H.-Y.; Hsu, C.-H.; Kuo, W.-H.; Chang, K.-J.; Juan, H.-F.; Huang, Tsui-Chin; Chang, Hsin-Yi; Hsu, Chun-Hua; Kuo, Wen-Hung; Chang, King-Jen; Juan, Hsueh-Fen; Huang, Tsui-Chin; Chang, Hsin-Yi; Hsu, Chun-Hua; Kuo, Wen-Hung; Chang, King-Jen; Juan, Hsueh-Fen |
| 臺大學術典藏 |
2022-08-12T06:28:04Z |
Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin b
|
Huang T.-C.; Chang H.-Y.; Hsu C.-H.; Kuo W.-H.; KING-JEN CHANG; Juan H.-F. |
| 國立臺灣大學 |
2008-04 |
Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B.
|
Huang, TC; Chang, HY; Hsu, CH; Kuo, WH; Chang, KJ; Juan, HF |
| 國立臺灣大學 |
2007 |
Targeting therapy on breast carcinoma by ATP synthase inhibitor Aurovertin B
|
Huang, T.-C.; Chang, H.-Y.; Juan, H.-F. |
| 中國醫藥大學 |
2013-12 |
Targeting Thymic Epithelia AR Enhances T-Cell Reconstitution and Bone Marrow Transplant Grafting Efficacy
|
(Lai KP);(Lai JJ);(Chang P);(Altuwaijri S);(Hsu JW);(Chuang KH);石志榮(Chih-Rong, Shyr);(Yeh S);張傳祥(Chawnshang Chang)* |
| 中山醫學大學 |
2012 |
Targeting to overexpressed glucose-regulated protein 78 in gastric cancer discovered by 2D DIGE improves the diagnostic and therapeutic efficacy of micelles-mediated system.
|
Cheng, CC; Lu, N; Peng, CL; Chang, CC; Mai, FD; Chen, LY; Liao, MH; Wang, WM; Chang, J |
| 國家衛生研究院 |
2013-03 |
Targeting to tumor-associated antigen eno1 provides preventive and therapeutic effects on disease progression of lung cancer
|
Shih, NY;Chang, GC;Tseng, SW;Liu, KJ;Hsiao, KC;Lin, HC |
| 中國醫藥大學 |
2015-01 |
Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals
|
(Ding X,);(Yang DR,);(Xia L);(Chen B,);(Yu S,);(Niu Y);(Wang M,);(Li G)*;張傳祥(Chawnshang Chang)* |
| 臺大學術典藏 |
2021-07-26T10:04:03Z |
Targeting triple?negative breast cancer with an aptamer?functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies
|
Chou Y.-T;Lin C.-Y;Wen J.-W;Hung L.-C;Chang Y.-F;Yang C.-M;Wu L.-C;Ho J.-A.A.; Chou Y.-T; Lin C.-Y; Wen J.-W; Hung L.-C; Chang Y.-F; Yang C.-M; Wu L.-C; Ho J.-A.A.; JA-AN ANNIE HO |
| 國立臺灣大學 |
2014 |
Targeting Tropomyosin-receptor Kinase Fused Gene in Cancer
|
Chen, Yun; Tseng, Sheng-Hong; 曾勝弘 |
| 臺大學術典藏 |
2020-03-12T08:24:34Z |
Targeting tropomyosin-receptor kinase fused gene in cancer
|
SHENG-HONG TSENG; Chen Y.; Chen Y.;Sheng-Hong Tseng |
| 國立臺灣大學 |
2016 |
Targeting TSLP With shRNA Alleviates Airway Inflammation and Decreases Epithelial CCL17 in a Murine Model of Asthma
|
Chen, Yi-Lien; Chiang, Bor-Luen; 江伯倫 |
| 臺大學術典藏 |
2020-06-27T06:39:04Z |
Targeting TSLP With shRNA Alleviates Airway Inflammation and Decreases Epithelial CCL17 in a Murine Model of Asthma
|
Chen Y.-L.;Bor-Luen Chiang; Chen Y.-L.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-07-02T03:41:26Z |
Targeting TSLP With shRNA Alleviates Airway Inflammation and Decreases Epithelial CCL17 in a Murine Model of Asthma
|
Chen Y.-L.;Bor-Luen Chiang; Chen Y.-L.; BOR-LUEN CHIANG |
| 國家衛生研究院 |
2017-07 |
Targeting tumor associated phosphatidylserine with new zinc dipicolylamine-based drug conjugates
|
Liu, YW;Shia, KS;Wu, CH;Liu, KL;Yeh, YC;Lo, CF;Chen, CT;Chen, YY;Yeh, TK;Chen, WH;Jan, JJ;Huang, YC;Huang, CL;Fang, MY;Gray, BD;Pak, KY;Hsu, TA;Huang, KH;Tsou, LK |
| 臺大學術典藏 |
2020-12-02T02:33:13Z |
Targeting Tumor Microenvironment by Bioreduction-Activated Nanoparticles for Light-Triggered Virotherapy
|
Tseng S.-J.;Kempson I.M.;Huang K.-Y.;Li H.-J.;Fa Y.-C.;Ho Y.-C.;Liao Z.-X.;Pan-Chyr Yang; Tseng S.-J.; Kempson I.M.; Huang K.-Y.; Li H.-J.; Fa Y.-C.; Ho Y.-C.; Liao Z.-X.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-02-25T04:02:59Z |
Targeting Tumor Microenvironment by Bioreduction-Activated Nanoparticles for Light-Triggered Virotherapy
|
Sj Tseng;Kempson I.M.;Huang K.-Y.;Li H.-J.;Fa Y.-C.;Ho Y.-C.;Liao Z.-X.;Yang P.-C.; SJ TSENG; Kempson I.M.; Huang K.-Y.; Li H.-J.; Fa Y.-C.; Ho Y.-C.; Liao Z.-X.; Yang P.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:11Z |
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Cheng A.-L.; CHIH-HUNG HSU; Liang C.-W.; Chang C.-J.;Yang Y.-H.;Chiu C.-J.;Lu L.-C.;Liao C.-C.;Liang C.-W.;Chih-Hung Hsu;Cheng A.-L.; Chang C.-J.; Yang Y.-H.; Chiu C.-J.; Lu L.-C.; Liao C.-C. |
| 臺大學術典藏 |
2021-03-15T07:44:44Z |
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Chang C.-J.;Yang Y.-H.;Chiu C.-J.;Li-Chun Lu;Liao C.-C.;Liang C.-W.;Hsu C.-H.;Cheng A.-L.; Chang C.-J.; Yang Y.-H.; Chiu C.-J.; LI-CHUN LU; Liao C.-C.; Liang C.-W.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2018 |
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Chang C.-J.;Yao-Hsu Yang;Chiu C.-J.;Lu L.-C.;Liao C.-C.;Liang C.-W.;Hsu C.-H.;Cheng A.-L.; Chang C.-J.; YAO-HSU YANG; Chiu C.-J.; Lu L.-C.; Liao C.-C.; Liang C.-W.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:29:29Z |
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Chang C.-J.; Yang Y.-H.; Chiu C.-J.; Lu L.-C.; Liao C.-C.; Liang C.-W.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T18:06:23Z |
Targeting tumor-infiltrating Ly6G+myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
|
Chang, C.-J.;Yang, Y.-H.;Chiu, C.-J.;Lu, L.-C.;Liao, C.-C.;Liang, C.-W.;Hsu, C.-H.;Cheng, A.-L.; ANN-LII CHENG |
| 國立成功大學 |
2016-11-10 |
Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer
|
Chien, C-W; Hou, P-C; Wu, H-C; Chang, Y-L; Lin, S-C; Lin, S-C; Lin, B-W; Lee, J-C; Chang, Y-J; Sun, H. S.; Tsai, S-J |
